West Pharmaceutical Services Inc reports results for the quarter ended March 31 - Earnings Summary

West Pharmaceutical Services

24/04/2025 14:32

West Pharmaceutical Services Inc WST.N reported quarterly adjusted earnings of $1.45​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of $1.56.  The mean expectation of eleven analysts for the quarter was for earnings of $1.23 per share. Wall Street expected results to range from $1.21  to $1.31 per share.

Revenue rose 0.4% to $698.00 million from a year ago; analysts expected $685.84 million.

West Pharmaceutical Services Inc's reported EPS for the quarter was $1.23​.

The company reported quarterly net income of $89.8 million.

West Pharmaceutical Services Inc shares had fallen by 2.5% this quarter and lost 33.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 26.1% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for West Pharmaceutical Services Inc is $275.00

This summary was machine generated from LSEG data April 24 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
1.23
1.45
Beat
Dec. 31 2024
1.72
1.82
Beat
Sep. 30 2024
1.50
1.85
Beat
Jun. 30 2024
1.74
1.52
Missed